UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Acquires 4,748 Shares of Definitive Healthcare Corp. (NASDAQ:DH)

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lifted its holdings in shares of Definitive Healthcare Corp. (NASDAQ:DH) by 6.2% in the fourth quarter, HoldingsChannel.com reports. The fund owned 81,358 shares of the company’s stock after acquiring an additional 4,748 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC’s holdings in Definitive Healthcare were worth $334,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds have also bought and sold shares of the company. Irenic Capital Management LP grew its position in shares of Definitive Healthcare by 9.2% during the 4th quarter. Irenic Capital Management LP now owns 7,003,194 shares of the company’s stock valued at $28,783,000 after acquiring an additional 590,009 shares during the period. Susquehanna Fundamental Investments LLC bought a new stake in shares of Definitive Healthcare in the 4th quarter worth approximately $1,181,000. Two Sigma Investments LP grew its holdings in Definitive Healthcare by 2,383.1% during the fourth quarter. Two Sigma Investments LP now owns 285,555 shares of the company’s stock valued at $1,174,000 after purchasing an additional 274,055 shares during the period. Sone Capital Management LLC purchased a new stake in Definitive Healthcare in the fourth quarter worth $953,000. Finally, Two Sigma Advisers LP increased its position in Definitive Healthcare by 1,301.5% in the fourth quarter. Two Sigma Advisers LP now owns 189,200 shares of the company’s stock worth $778,000 after buying an additional 175,700 shares during the last quarter. 98.67% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

DH has been the topic of a number of recent research reports. The Goldman Sachs Group upped their price target on Definitive Healthcare from $3.00 to $3.40 and gave the company a “neutral” rating in a research report on Monday, May 12th. Barclays lowered their price objective on Definitive Healthcare from $4.00 to $3.00 and set an “underweight” rating on the stock in a research note on Monday, March 3rd. Wall Street Zen lowered shares of Definitive Healthcare from a “buy” rating to a “hold” rating in a research report on Saturday, May 31st. Finally, BTIG Research downgraded shares of Definitive Healthcare from a “buy” rating to a “neutral” rating in a research note on Friday, May 9th. Two equities research analysts have rated the stock with a sell rating, eight have given a hold rating and one has assigned a buy rating to the stock. According to MarketBeat.com, the stock has an average rating of “Hold” and an average target price of $5.10.

Definitive Healthcare Stock Down 3.2%

Shares of NASDAQ DH opened at $3.63 on Friday. The company has a quick ratio of 2.49, a current ratio of 2.49 and a debt-to-equity ratio of 0.33. The company has a market cap of $539.57 million, a P/E ratio of -1.17, a P/E/G ratio of 4.06 and a beta of 1.58. Definitive Healthcare Corp. has a 52 week low of $2.15 and a 52 week high of $6.16. The business has a 50-day simple moving average of $3.02 and a two-hundred day simple moving average of $3.73.

Definitive Healthcare (NASDAQ:DH) last announced its quarterly earnings results on Thursday, May 8th. The company reported $0.05 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.02 by $0.03. The firm had revenue of $59.19 million for the quarter, compared to the consensus estimate of $56.20 million. Definitive Healthcare had a negative net margin of 142.38% and a positive return on equity of 1.76%. The company’s revenue for the quarter was down 6.8% on a year-over-year basis. During the same period in the prior year, the firm posted $0.08 earnings per share. Research analysts anticipate that Definitive Healthcare Corp. will post 0.16 earnings per share for the current fiscal year.

About Definitive Healthcare

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.